Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed Jan 29, 2014
Filed with the SEC on Jan 29, 2014 and accepted by EDGAR at Jan 29, 2014, 21:38 ET.
Items reported
- Item 2.01 Completion of an acquisition or disposition
- Item 2.02 Results of operations
- Item 2.06 Material impairments
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000875320-14-000007. Last ingested by Listed: Nov 6, 2026, 12:56 ET. Listed shows no prices and gives no investment advice.